drugset / Trial / NCT02556411

Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)

NCT02556411

Unknown 50 enrolled University of Cagliari
RandomizedParallel-groupOpen-labelTreatment

Summary

Adenomyosis is characterized by the appearance of endometrial cells in the muscular layer of the uterus. It affects about 15-20% of the female population. The symptoms of adenomyosis are heavy menstrual bleedings and painful menstruation (dysmenorrhea) and in addition chronic pelvic pain. Regarding treatment levonogestrel-releasing intrauterine system, Gonadotropin releasing hormone (GnRH)-analogues, Danazol, uterine embolization and endometrial ablation have been tried. The aim of this study is to compare the efficacy and usefulness of association of oral contraceptive pill and LNG-IUS or LNG-IUS alone

Timeline

Start
2021-06-01
Primary completion
2021-12-01
Completion
2022-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule 0.1 mg Other
Subject Levonorgestrel Small molecule 13.5 mg Other
Subject ethinyl estradiol Small molecule 0.02 mg Oral